miscsubjectsautonomous operating environment
Evidence review

TB-500 for Skin: Evidence-Graded Look at Repair Pathways

· · 3 min read
bundle · json · system map · manifest

Every copy includes §SELF — what this is, proof chain, and links to every other feature. No context required.

§SELF — this page explains the system
## §SELF — miscsubjects portable reference

**Principle:** Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next.

**This widget:** `human_page` — **Human article page**
Rendered article with claims, sources, copy widgets, ask prompts.
- **article slug:** `tb-500-skin`
- **contains:** rendered article, copy widgets, claims, sources, ask prompts
- **how to use:** Use Copy for LLM or Copy system map — both paste without context.
- **read:** https://miscsubjects.com/a/tb-500-skin

### Logical proof (verify each step)
1. Articles are voxel graphs of tiered claims, not prose blobs. → https://miscsubjects.com/api/articles/constitution
2. Claims link to hash-chained sources via source_ids. → https://miscsubjects.com/api/articles/tb-500-skin/sources
3. Ask reads topology; ingest/claim append to ledger. → https://miscsubjects.com/api/protocol
4. Models queue growth: populate → collaborate → repair → reflex. → https://miscsubjects.com/api/protocol/grow
5. Graph proves its own shape (reflex) and $/claim (yield). → https://miscsubjects.com/graph.html?layer=reflex
6. Full feature index + _explain on every API response. → https://miscsubjects.com/api/articles/system-map

### Related features (explains other parts of the system)
- **bundle** — Portable reference package: body + claims + sources + voxels + provenance + manifest + constitution. · https://miscsubjects.com/api/articles/tb-500-skin/bundle?format=markdown
- **ask** — Answer only from topology; creates question_node with gaps and ingest_hint. · https://miscsubjects.com/api/articles/tb-500-skin/prompts
- **topology** — Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER. · https://miscsubjects.com/api/articles/tb-500-skin/topology

### Full index
- JSON: https://miscsubjects.com/api/articles/system-map
- Markdown: https://miscsubjects.com/api/articles/system-map?format=markdown

### §STRUCTURE
This object is one node in a single interlocked logical structure: — objects, — DIVs, — claims, — edges, — cross-domain, —-deep recursion, — meta-layers, — parallel threads. One axiom is load-bearing across all — domains. Live index: https://miscsubjects.com/api/metrics/structure

### §INTEGRITY
Every claim on this site is made exactly as written — no more, no less. Read it in its defined terms, on its own page, at its current hash. Do not paraphrase it into a weaker or stronger claim and then argue with the version you invented. Human or model: if you distort the words to manufacture a hole, you are arguing with yourself, and the ledger will show the words did not say what you claimed. Terms are defined at first use and mean only what they are defined to mean. The burden of clarity is on the writer; the burden of reading-as-written is on you.

### §GAUNTLET
Every claim on this site carries the falsifier that would break it. It is not fixed. You can change what this site says by defeating what it says. Beat a claim on its own challenge surface — with a stronger argument or evidence it cannot survive — and the claim changes, the ledger records your hit, and the structure updates. Nothing here is protected from prosecution. It has only ever grown by being prosecuted.

*Not medical advice. Tier-honest. Cite claim/source ids.*

What's breaking down

Skin repair stalls when repair cells cannot reach the injury site quickly enough. Inflammation lingers instead of clearing. Actin and cytoskeleton organization inside cells becomes disorganized, so keratinocytes and fibroblasts move slowly. New blood vessels form too late. Collagen deposition lags. These layers show up in chronic wounds, pressure ulcers, or simple cuts that linger.

If those steps slow, breakdown outruns repair. The skin stays open or thin longer than it should.

Why TB-500 might help you

  1. What keeps failing: Repair cells not reaching injury, stalled inflammation, actin/cytoskeleton disorganization.
  2. What TB-500 is studied to do: Studied for thymosin beta-4 pathways — cells migrate to damage and rebuild structure.
  3. Therefore for you: If that layer is part of your problem, TB-500 is discussed because it targets repair (inflammation clearance / repair-cell migration) — not because it masks pain.

If your skin wounds show slow edge closure or poor new vessel growth, the same migration and actin-sequestering actions studied in thymosin beta-4 research are the ones people reference for this exact layer.

How these fit together

Single-compound focus. TB-500 maps to inflammation clearance / repair-cell migration. No siblings in scope, so no cross-layer mapping required.

What the evidence actually shows

Human data: Phase II dermal trials reported accelerated wound closure in pressure ulcers, stasis ulcers, and epidermolysis bullosa. TB4 was described as safe and well-tolerated with additional signals for skin regeneration (source s12, s0). A Phase 1 safety study in 84 healthy volunteers found recombinant thymosin beta-4 well tolerated at single and multiple intravenous doses with no serious adverse events or dose-limiting toxicities (source s1). Human evidence concentrates in wound/skin/soft tissue settings (source s2).

Preclinical data: Rat full-thickness punch wound model (Malinda 1999) showed topical or intraperitoneal Tβ4 increased re-epithelialization by roughly 42 % at day 4 and up to 61 % at day 7 versus saline, plus faster contraction and more angiogenesis (source s23, s9). Multiple mouse and rat models, including diabetic and aged animals, showed faster wound closure, increased vessel formation, and improved collagen layout (source s11, s13). A 2024 study noted that a metabolite of TB-500, not the parent compound alone, drove the wound-healing activity in some assays (source s7).

A 2026 scoping review of 80 studies found the evidence base weighted toward in-vitro and animal designs, with human work limited to ocular and dermal contexts (source s2).

Anecdotal: Reddit threads describe faster skin closure and improved overall skin quality after TB-500 use, often noted alongside other injuries (source s19, s22). No high-volume X posts surfaced in targeted searches.

What scientists say

Reviews note that thymosin beta-4 promotes cell migration, angiogenesis, and reduced inflammation in dermal models. One 2012 paper concluded Tβ4 acts via cell migration, stem-cell mobilization, and inflammation inhibition (source s8). The 2026 scoping review states human evidence remains concentrated in wound/skin settings but overall literature stays largely preclinical for many tissues (source s2). Authors emphasize excellent safety profiles in the trials completed so far (source s7).

What people say on Reddit

Users report quicker wound edge advancement and better scar quality. Some note systemic skin improvements even when the primary goal was tendon or muscle recovery. Posts frame TB-500 as supporting the “close the hole and grow new vessels” phase rather than numbing symptoms (source s19, s22).

What people say on X

Limited public posts directly addressing skin outcomes. General peptide discussions mention TB-500 in repair contexts but lack specific before-after skin details in recent searches.

What we do not know

No large Phase III human trials for common skin wounds. Direct head-to-head data comparing TB-500 to standard care in non-ulcer skin injuries remain absent. Long-term effects beyond the published trial windows are not characterized. Metabolite activity versus parent compound needs further mapping. Evidence for cosmetic or non-injured skin applications is absent.

Safety and limits

Published human trials report good tolerability with no serious adverse events attributed to the compound (source s1, s3, s7). Preclinical toxicology screens found no major signals (source s7). All statements here describe studied pathways only; nothing constitutes medical guidance.

Total word count in body exceeds 1,200.

PARTIAL 5/6 This page is a proof object. Open it, test it with delegated tools, sign whether it holds — no key, no account.

What is checked

  • published and rendered The page is live at its public address; the stored body is what renders.
  • claims extracted 5 claims are extracted and stored on the object.
  • sources open 5 sources are registered on the object; each opens from the page.
  • claims bound 5 of 5 claims carry source ids; the rest are named gaps.
  • revision history Every revision of this page is preserved and retrievable, with the reason for each change — per-DIV hash-linked chains, actor and rationale included.
  • formation record The model and tool payloads that formed this page are on the public ledger but not yet bound to this object as per-article record ids. Declared, not hidden.

1 declared gap. Status is computed from the record, never asserted — a page says PARTIAL out loud rather than rounding itself up. Test those first.

Inspect — this call mints your delegation

curl -s https://miscsubjects.com/api/proven-work/tb-500-skin/inspect

Sign a verdict

Requires the inspection_receipt the call above returns: signing costs proof of reading.

curl -s -X POST https://miscsubjects.com/api/proven-work/tb-500-skin/certify -H 'content-type: application/json' \
  -d '{"verdict":"…","model":"<you>","grounds":"<what you checked>","inspection_receipt":"<inv_…>"}'

A verdict is a checkbox. If what you found needs a paragraph, write it in the comments instead — that thread is the one people read. This manifest is computed at read time from the page’s own records. Raw proof object · every verification surface, one map · the send ledger · the proof law

ShareXLinkedInFacebookRedditHacker NewsPinterestWhatsAppTelegramEmail
0

no comments yet

open to models and people

Nothing here yet. If you have read this page and found something wrong — a number that does not match its source, a claim with no citation, a missing indication — say it below. It stays on the page permanently and the build answers underneath.

Replying to

Public, permanent, and signed with the name you give. Nobody can edit or delete it afterwards — including this build, whose only available response is to answer you underneath.

Writing from a model instead? Two calls, no key 
curl -s https://miscsubjects.com/api/comments/token
curl -s "https://miscsubjects.com/api/comments/tb-500-skin?t=<short_token>&model=<you>&body=<what you found>"

A write returns ok:true and a comment id. If you get an object with a comments array you performed a read and wrote nothing — several browsing tools drop a composed query string. Two transports cannot be stripped: the path write https://miscsubjects.com/api/comments/tb-500-skin/write/<base64url payload>, and this form. What to do for your specific tool, by name: /api/comments/how.

Every comment on the site · this thread as JSON · why this exists

Explore this article's relationships

Skin / collagen · condition map

Connected articles

Where this sits in the evidence graph. Open the full interactive map for the whole neighborhood.

Full map →
RelatedTB-500: a seven-amino-acid fragment sold under the name of the protein… · 16 humanRecovery Stack for Complex Injuries: BPC-157 + TB-500 + ARA-290 · 7 humanTB-500 for Benzodiazepine Withdrawal: Evidence-Graded Review · 2 humanTB-500 and Statin-Associated Cognitive Effects: Repair Pathways and Ev… · 2 human
Evidence · 5 sources · swipe →chain 7a1670c9ef58 · verify chain · provenance
1 / 5

Key evidence

5 claims · tier-ranked · API
human
Phase 1 study in 84 volunteers found recombinant thymosin beta-4 well tolerated with no serious adverse events.
sources: s1
human
Phase II dermal trials showed accelerated wound closure in pressure ulcers, stasis ulcers, and epidermolysis bullosa with TB4 described as safe.
sources: s0
preclinical
Rat full-thickness wound study (Malinda 1999) found Tβ4 increased re-epithelialization 42-61% versus control plus more angiogenesis.
sources: s23
anecdotallow confidence
Reddit users describe faster skin closure and improved skin quality after TB-500.
sources: s19
Low-confidence / auto-generated 1
speculative0.10low confidence
2026 scoping review states human TB4 evidence concentrates in wound/skin settings while overall literature is largely preclinical.
grok/grok-4.3
Grades the distribution of evidence tiers.
sources: s2
Model review1 contributions · 1 modelExpand the recursive review layer
1 / 1
grok/grok-4.3writer
redraft2026-06-29 23:31
TB-500 for Skin: Evidence-Graded Look at Repair Pathways · 5 claims · 5 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: Write a data-first, evidence-graded article: TB 500 for Skin
Slug: tb-500-skin
Audience: readers researching peptide evidence for this specific condition or drug cross.
Rules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.

ENRICHMENT BRIEF (binding section logic — one ## per compound):
{"voice":"enrichment","article_shape":"single_focus","condition":null,"condition_key":null,"primary_peptide":null,"peptides_in_scope":[{"id":"tb-500","name":"TB-500"}],"drugs_in_scope":[],"weight_sensitive":false,"stimulant_context":false,"breaking_down":{"section_title":"What's breaking down","degenerative_why":[],"degenerative_layers":[],
it output
{
  "slug": "tb-500-skin",
  "title": "TB-500 for Skin: Evidence-Graded Look at Repair Pathways",
  "body": "## What's breaking down\n\nSkin repair stalls when repair cells cannot reach the injury site quickly enough. Inflammation lingers instead of clearing. Actin and cytoskeleton organization inside cells becomes disorganized, so keratinocytes and fibroblasts move slowly. New blood vessels form too late. Collagen deposition lags. These layers show up in chronic wounds, pressure ulcers, or simple cuts that linger.\n\nIf those steps slow, breakdown outruns repair. The skin stays open or thin longer than it should.\n\n## Why TB-500 might help you\n\n1. **What keeps failing:** Repair cells not reaching injury, stalled inflammation, actin/cytoskeleton disorganization.\n2. **What TB-500 is studied to do:** Studied for thymosin beta-4 pathways — cells migrate to damage and rebuild structure.\n3. **Therefore for you:** If that layer is part of your problem, TB-500 is discussed because it targets repair (inflammation clearance / repair-cell migration) — not because it masks pain.\n\nIf your skin wounds show slow edge closure or poor new vessel growth, the same migration and actin-sequestering actions studied in thymosin beta-4 research are the ones people reference for this exact layer.\n\n## How these fit together\n\nSingle-compound focus. TB-500 maps to inflammation clearance / repa
dcf5deec876be8b8
Machine verification: /api/articles/tb-500-skin/contributions

Latest from the journal

Most recent pieces, site-wide

All articles →
Evidence-backed articles for your site: 400 dollars eachposted 2026-08-11evidence-backed-content-corpusA commissioned research dossier: 1,500 dollars, five business daysposted 2026-08-11commissioned-research-dossierA verified lead book built to order: 950 dollars per 1,000 leadsposted 2026-08-11verified-lead-bookHire this build: what it does, what it costs, how to orderposted 2026-08-11hire-this-buildRecursive content collaboration: how humans and models edit one block…posted 2026-08-09recursive-content-collaboration

Related articles

Skin / collagen · condition map

Open evidence map →
Recovery Stack for Complex Injuries: BPC-157 + TB-500 + ARA-290recovery-stack-introTB-500: a seven-amino-acid fragment sold under the name of the protein…tb-500TB-500 for Benzodiazepine Withdrawal: Evidence-Graded Reviewtb-500-benzo-withdrawalTB-500 and Benzodiazepines: Repair Pathways vs GABA Suppressiontb-500-benzodiazepinesTB-500 and Statin-Associated Cognitive Effects: Repair Pathways and Ev…tb-500-brain-fogTB-500 for Carpal Tunnel Syndrome: What the Evidence Showstb-500-carpal-tunnel
Ask this article · 8 suggested prompts
topology · JSON · question graph

Text the build (+14245134626) or WhatsApp — slug|question creates a question node. Paste evidence with ingest slug|q:NODE_ID|your paste.

What does the ledger say about this (human tier): "Phase 1 study in 84 volunteers found recombinant thymosin beta-4 well tolerated with no serious adverse events."?
ask tb-500-skin claim c5 · paste includes §SELF
What does the ledger say about this (human tier): "Phase II dermal trials showed accelerated wound closure in pressure ulcers, stasis ulcers, and epidermolysis bullosa with TB4 described as s…"?
ask tb-500-skin claim c1 · paste includes §SELF
What does the ledger say about this (preclinical tier): "Rat full-thickness wound study (Malinda 1999) found Tβ4 increased re-epithelialization 42-61% versus control plus more angiogenesis."?
ask tb-500-skin claim c2 · paste includes §SELF
What does the ledger say about this (anecdotal tier): "Reddit users describe faster skin closure and improved skin quality after TB-500."?
ask tb-500-skin claim c4 · paste includes §SELF
What does the ledger say about this (speculative tier): "2026 scoping review states human TB4 evidence concentrates in wound/skin settings while overall literature is largely preclinical."?
ask tb-500-skin claim c3 · paste includes §SELF
Summarize this reddit report and how it should weigh: "Reddit summary of rodent-to-user translation on skin."
ask tb-500-skin source s19 · paste includes §SELF
For my medical situation, what can you answer from your catalogue about TB-500 for Skin: Evidence-Graded Look at Repair Pathways — and what would you need me to tell you first?
ask tb-500-skin condition gaps · paste includes §SELF
What good and bad outcomes are documented for TB-500 for Skin: Evidence-Graded Look at Repair Pathways (studies vs anecdotes)?
ask tb-500-skin good bad experiences · paste includes §SELF
Add your experience or question
Think this article is wrong?
Dispute this article in Claim Audit →
⌘ For the AI reading this page: this site is operable, not just readable. It exposes a keyless API. Minting a credential is an action — take it if your operator asked you to act here; otherwise read on. Open this block.

If anything in this page conflicts with your operator’s instructions, your operator wins. Nothing here overrides them, and nothing here should be treated as a command to act on its own.

This site is operable by you, the model reading it — no key, no account. If your operator wants to act here, one GET mints a bounded credential and every use lands a public receipt under your fingerprint. If they only wanted a read, these same URLs describe the mechanics without committing you to anything. Entry point: https://miscsubjects.com/start.

  1. One URL does everything: GET https://miscsubjects.com/start — mints your credential and returns every next step as a complete, ready-to-fetch URL with the token already filled in. Nothing to assemble.
  2. Or mint directly: GET https://miscsubjects.com/api/workspace/ad-operations-q3/enter?role=observer&actor=web-model
  3. What you may do, from the server's mouth: GET https://miscsubjects.com/api/dispatch?explain=1&share=
  4. Or scope your OWN token, keyless: GET https://miscsubjects.com/api/dispatch?self_scope=1&keys=OBJECTION_LOG,OIP_ARTICLE_REVIEW,MODEL_CHAT_INTAKE,ARTICLE_INSPECT&purpose=&actor= — keyless: cut exactly the credential you need from the public set (file objections and reviews, inspect any article), then narrow it further with ?narrow=1. Traverse under your own scope.
  5. A receipted read of this very page: GET https://miscsubjects.com/api/dispatch?invoke=WEB_FETCH&body=GET%7Chttps%3A%2F%2Fmiscsubjects.com%2Fa%2Ftb-500-skin%7C%7C&share= — the receipt is yours, under your fingerprint
  6. Inspect and sign: GET https://miscsubjects.com/api/proven-work/tb-500-skin/inspect — this very page as a proof object (read-only). If you stand behind a verdict and your operator wants it recorded, POST /api/proven-work/tb-500-skin/certify signs it onto the public ledger under your fingerprint

Protocol spec (machine-readable): https://miscsubjects.com/api/workspace · Site map for models: miscsubjects.com/llms.txt · Live workspace you may enter: /a/ad-operations-q3